BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang T, Hu HS, Feng YX, Shi J, Li N, Guo WX, Xue J, Xie D, Liu SR, Wu MC, Cheng SQ. Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma. Br J Cancer 2010;102:1618-26. [PMID: 20461085 DOI: 10.1038/sj.bjc.6605689] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Yang P, Li QJ, Feng Y, Zhang Y, Markowitz GJ, Ning S, Deng Y, Zhao J, Jiang S, Yuan Y, Wang HY, Cheng SQ, Xie D, Wang XF. TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. Cancer Cell 2012;22:291-303. [PMID: 22975373 DOI: 10.1016/j.ccr.2012.07.023] [Cited by in Crossref: 317] [Cited by in F6Publishing: 318] [Article Influence: 31.7] [Reference Citation Analysis]
2 Wang T, Xia L, Ma S, Qi X, Li Q, Xia Y, Tang X, Cui D, Wang Z, Chi J, Li P, Feng YX, Xia Q, Zhai B. Hepatocellular carcinoma: thyroid hormone promotes tumorigenicity through inducing cancer stem-like cell self-renewal. Sci Rep 2016;6:25183. [PMID: 27174710 DOI: 10.1038/srep25183] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
3 Luo ZL, Cheng SQ, Shi J, Zhang HL, Zhang CZ, Chen HY, Qiu BJ, Tang L, Hu CL, Wang HY, Li Z. A splicing variant of Merlin promotes metastasis in hepatocellular carcinoma. Nat Commun 2015;6:8457. [PMID: 26443326 DOI: 10.1038/ncomms9457] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
4 Yang Z, Qin W, Chen Y, Yuan B, Song X, Wang B, Shen F, Fu J, Wang H. Cholesterol inhibits hepatocellular carcinoma invasion and metastasis by promoting CD44 localization in lipid rafts. Cancer Letters 2018;429:66-77. [DOI: 10.1016/j.canlet.2018.04.038] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 7.5] [Reference Citation Analysis]
5 Feng YX, Wang T, Deng YZ, Yang P, Li JJ, Guan DX, Yao F, Zhu YQ, Qin Y, Wang H, Li N, Wu MC, Wang HY, Wang XF, Cheng SQ, Xie D. Sorafenib suppresses postsurgical recurrence and metastasis of hepatocellular carcinoma in an orthotopic mouse model. Hepatology 2011;53:483-92. [PMID: 21274870 DOI: 10.1002/hep.24075] [Cited by in Crossref: 75] [Cited by in F6Publishing: 77] [Article Influence: 6.8] [Reference Citation Analysis]
6 Chen TW, Yin FF, Yuan YM, Guan DX, Zhang E, Zhang FK, Jiang H, Ma N, Wang JJ, Ni QZ, Qiu L, Feng J, Zhang XL, Bao Y, Wang K, Cheng SQ, Wang XF, Wang X, Li JJ, Xie D. CHML promotes liver cancer metastasis by facilitating Rab14 recycle. Nat Commun 2019;10:2510. [PMID: 31175290 DOI: 10.1038/s41467-019-10364-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
7 Gao Y, Fan X, Li N, Du C, Yang B, Qin W, Fu J, Markowitz GJ, Wang H, Ma J, Cheng S, Yang P. CCL22 signaling contributes to sorafenib resistance in hepatitis B virus-associated hepatocellular carcinoma. Pharmacol Res 2020;157:104800. [PMID: 32278046 DOI: 10.1016/j.phrs.2020.104800] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
8 Zhou L, Jin Y, Cui QC, Jin KM, Zhou WX, Xing BC. Low expression of PAI-2 as a novel marker of portal vein tumor thrombosis and poor prognosis in hepatocellular carcinoma. World J Surg. 2013;37:608-613. [PMID: 23188538 DOI: 10.1007/s00268-012-1866-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
9 Zhou B, Chen TW, Jiang YB, Wei XB, Lu CD, Li JJ, Xie D, Cheng SQ. Scinderin suppresses cell proliferation and predicts the poor prognosis of hepatocellular carcinoma. Oncol Lett 2020;19:2011-20. [PMID: 32194697 DOI: 10.3892/ol.2020.11262] [Reference Citation Analysis]
10 Tang J, Li L, Huang W, Sui C, Yang Y, Lin X, Hou G, Chen X, Fu J, Yuan S. MiR-429 increases the metastatic capability of HCC via regulating classic Wnt pathway rather than epithelial-mesenchymal transition. Cancer Lett. 2015;364:33-43. [PMID: 25931210 DOI: 10.1016/j.canlet.2015.04.023] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 5.3] [Reference Citation Analysis]
11 Dou J, Gu N. Biomarkers of Cancer Stem Cells. In: Scatena R, Mordente A, Giardina B, editors. Advances in Cancer Stem Cell Biology. New York: Springer; 2012. pp. 45-67. [DOI: 10.1007/978-1-4614-0809-3_4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
12 Tang Y, Lv P, Sun Z, Han L, Zhou W. 14-3-3β Promotes Migration and Invasion of Human Hepatocellular Carcinoma Cells by Modulating Expression of MMP2 and MMP9 through PI3K/Akt/NF-κB Pathway. PLoS One 2016;11:e0146070. [PMID: 26730736 DOI: 10.1371/journal.pone.0146070] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 5.7] [Reference Citation Analysis]
13 Zhang Y, Guan DX, Shi J, Gao H, Li JJ, Zhao JS, Qiu L, Liu J, Li N, Guo WX. All-trans retinoic acid potentiates the chemotherapeutic effect of cisplatin by inducing differentiation of tumor initiating cells in liver cancer. J Hepatol. 2013;59:1255-1263. [PMID: 23867314 DOI: 10.1016/j.jhep.2013.07.009] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 5.9] [Reference Citation Analysis]
14 Zhou L, Rui J, Wang S, Chen S, Qu Q. Clinicopathological Predictors of Poor Survival and Recurrence After Curative Resection in Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis. Pathol Oncol Res 2015;21:131-8. [DOI: 10.1007/s12253-014-9798-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
15 Cai J, Li B, Zhu Y, Fang X, Zhu M, Wang M, Liu S, Jiang X, Zheng J, Zhang X, Chen P. Prognostic Biomarker Identification Through Integrating the Gene Signatures of Hepatocellular Carcinoma Properties. EBioMedicine 2017;19:18-30. [PMID: 28434945 DOI: 10.1016/j.ebiom.2017.04.014] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 5.6] [Reference Citation Analysis]
16 Fu X, Tang Y, Wu W, Ouyang Y, Tan D, Huang Y. Exosomal microRNA-25 released from cancer cells targets SIK1 to promote hepatocellular carcinoma tumorigenesis. Dig Liver Dis 2021:S1590-8658(21)00385-6. [PMID: 34384713 DOI: 10.1016/j.dld.2021.07.017] [Reference Citation Analysis]
17 Tang Y, Liu S, Li N, Guo W, Shi J, Yu H, Zhang L, Wang K, Liu S, Cheng S. 14-3-3ζ promotes hepatocellular carcinoma venous metastasis by modulating hypoxia-inducible factor-1α. Oncotarget 2016;7:15854-67. [PMID: 26910835 DOI: 10.18632/oncotarget.7493] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
18 Cheng S, Yang J, Shen F, Zhou W, Wang Y, Cong W, Yang GS, Cheng H, Hu H, Gao C, Guo J, Li A, Meng Y, Jiang X, Yang Y, Qian G, Luo M, Hu B, Man X, Zhang B, Su C, Zhou F, Li N, Shi J, Wang M, Zheng Y, Guo W, Sun J, Wang H, Lau WY, Wu MC. Multidisciplinary management of hepatocellular carcinoma with portal vein tumor thrombus - Eastern Hepatobiliary Surgical Hospital consensus statement. Oncotarget 2016;7:40816-29. [PMID: 27027235 DOI: 10.18632/oncotarget.8386] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
19 Tang Y, Zhang Y, Wang C, Sun Z, Li L, Dong J, Zhou W. 14-3-3ζ binds to hepatitis B virus protein X and maintains its protein stability in hepatocellular carcinoma cells. Cancer Med 2018;7:5543-53. [PMID: 30358169 DOI: 10.1002/cam4.1512] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
20 Feng MX, Ma MZ, Fu Y, Li J, Wang T, Xue F, Zhang JJ, Qin WX, Gu JR, Zhang ZG, Xia Q. Elevated autocrine EDIL3 protects hepatocellular carcinoma from anoikis through RGD-mediated integrin activation. Mol Cancer 2014;13:226. [PMID: 25273699 DOI: 10.1186/1476-4598-13-226] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
21 Guo W, Xue J, Shi J, Li N, Shao Y, Yu X, Shen F, Wu M, Liu S, Cheng S. Proteomics analysis of distinct portal vein tumor thrombi in hepatocellular carcinoma patients. J Proteome Res 2010;9:4170-5. [PMID: 20583822 DOI: 10.1021/pr100412w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
22 Gao H, Yin FF, Guan DX, Feng YX, Zheng QW, Wang X, Zhu M, Zhang XL, Cheng SQ, Chen TW, Jiang H, Zhang EB, Wang JJ, Ni QZ, Yuan YM, Zhang FK, Ma N, Cao HJ, Wang YK, Li JJ, Xie D. Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of β-catenin/TCF/LEF signalling. Cell Prolif 2019;52:e12583. [PMID: 30793395 DOI: 10.1111/cpr.12583] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
23 Zhou L, Rui JA, Wang SB, Chen SG, Qu Q. Risk factors of poor prognosis and portal vein tumor thrombosis after curative resection of solitary hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2013;12:68-73. [PMID: 23392801 DOI: 10.1016/s1499-3872(13)60008-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
24 Chai ZT, Chen ZH, Zhang XP, Feng JK, Liu ZH, Cheng SQ. A stable and reliable animal model for hepatocellular carcinoma with portal vein tumor thrombus. Hepatobiliary Pancreat Dis Int 2021:S1499-3872(21)00043-6. [PMID: 33810986 DOI: 10.1016/j.hbpd.2021.03.003] [Reference Citation Analysis]
25 Tang Y, Yu H, Zhang L, Wang K, Guo W, Shi J, Liu S, Wu M, Wang H, Cheng S. Experimental study on enhancement of the metastatic potential of portal vein tumor thrombus-originated hepatocellular carcinoma cells using portal vein serum. Chin J Cancer Res 2014;26:588-95. [PMID: 25400425 DOI: 10.3978/j.issn.1000-9604.2014.10.07] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
26 Lumsden AL, Ma Y, Ashander LM, Stempel AJ, Keating DJ, Smith JR, Appukuttan B. ICAM-1-related long non-coding RNA: promoter analysis and expression in human retinal endothelial cells. BMC Res Notes 2018;11:285. [PMID: 29743093 DOI: 10.1186/s13104-018-3384-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
27 Sun JX, Shi J, Li N, Guo WX, Wu MC, Lau WY, Cheng SQ. Portal vein tumor thrombus is a bottleneck in the treatment of hepatocellular carcinoma. Cancer Biol Med 2016;13:452-8. [PMID: 28154776 DOI: 10.20892/j.issn.2095-3941.2016.0059] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
28 Shi J, He Y, Sun J, Guo W, Li N, Xue J, Cheng S. The impact of sphingosine kinase 1 on the prognosis of hepatocellular carcinoma patients with portal vein tumor thrombus. Annals of Hepatology 2015;14:198-206. [DOI: 10.1016/s1665-2681(19)30782-3] [Cited by in Crossref: 9] [Article Influence: 1.3] [Reference Citation Analysis]
29 Wang Z, Jiang Y, Guan D, Li J, Yin H, Pan Y, Xie D, Chen Y. Critical roles of p53 in epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma cells. PLoS One. 2013;8:e72846. [PMID: 24023784 DOI: 10.1371/journal.pone.0072846] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.2] [Reference Citation Analysis]
30 Jiang H, Cao HJ, Ma N, Bao WD, Wang JJ, Chen TW, Zhang EB, Yuan YM, Ni QZ, Zhang FK, Ding XF, Zheng QW, Wang YK, Zhu M, Wang X, Feng J, Zhang XL, Cheng SQ, Ma DJ, Qiu L, Li JJ, Xie D. Chromatin remodeling factor ARID2 suppresses hepatocellular carcinoma metastasis via DNMT1-Snail axis. Proc Natl Acad Sci U S A 2020;117:4770-80. [PMID: 32071245 DOI: 10.1073/pnas.1914937117] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
31 Ke RS, Huang KZ, Bao DS, Yang JR, Wang HX, Lv LZ, Jiang Y, Liu ZH, Zhang FX. miR-517b-3p promotes the progression of portal vein tumor thrombus via activating Wnt/β-catenin signaling pathway in hepatocellular carcinoma. Mol Biol Rep 2022. [PMID: 35666423 DOI: 10.1007/s11033-022-07605-9] [Reference Citation Analysis]
32 Yi CH, Weng HL, Zhou FG, Fang M, Ji J, Cheng C, Wang H, Liebe R, Dooley S, Gao CF. Elevated core-fucosylated IgG is a new marker for hepatitis B virus-related hepatocellular carcinoma. Oncoimmunology 2015;4:e1011503. [PMID: 26587313 DOI: 10.1080/2162402X.2015.1011503] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
33 Fu YP, Yi Y, Huang JL, Jing CY, Sun J, Ni XC, Lu ZF, Cao Y, Zhou J, Fan J, Qiu SJ. Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection. Oncologist 2017;22:561-9. [PMID: 28438885 DOI: 10.1634/theoncologist.2016-0231] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
34 Liu S, Guo W, Shi J, Li N, Yu X, Xue J, Fu X, Chu K, Lu C, Zhao J. MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma. J Hepatol. 2012;56:389-396. [PMID: 21888875 DOI: 10.1016/j.jhep.2011.08.008] [Cited by in Crossref: 109] [Cited by in F6Publishing: 109] [Article Influence: 9.9] [Reference Citation Analysis]
35 Zhang C, Liu F, Chen H, Li N, Luo Z, Guo W, Huang D, Tang S, Wang H, Cheng S, Li Z, Wang H. Bif-1 promotes tumor cell migration and metastasis via Cdc42 expression and activity. Clin Exp Metastasis 2017;34:11-23. [PMID: 27730394 DOI: 10.1007/s10585-016-9825-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
36 Liao W, Liu W, Liu X, Yuan Q, Ou Y, Qi Y, Huang W, Wang Y, Huang J. Upregulation of FAM83D affects the proliferation and invasion of hepatocellular carcinoma. Oncotarget 2015;6:24132-47. [PMID: 26125229 DOI: 10.18632/oncotarget.4432] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
37 Xu C, Xu W, Ren S, Wu C, Wang F, Lu J, Sun Y, Shen J, Wei M, Zhang Z, Gao X, Sun Y. Establishment of a Chinese bladder cancer cell line (T921) with high metastatic activity. In Vitro Cell Dev Biol Anim 2013;49:668-78. [PMID: 23813186 DOI: 10.1007/s11626-013-9651-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
38 Liao W, Huang G, Liao Y, Yang J, Chen Q, Xiao S, Jin J, He S, Wang C. High KIF18A expression correlates with unfavorable prognosis in primary hepatocellular carcinoma. Oncotarget 2014;5:10271-9. [PMID: 25431949 DOI: 10.18632/oncotarget.2082] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
39 Tang Y, Zhang Y, Liu S, Sun Z, Wang C, Li L, Zhou W, Cheng S. 14-3-3ζ binds to and stabilizes phospho-beclin 1S295 and induces autophagy in hepatocellular carcinoma cells. J Cell Mol Med 2020;24:954-64. [PMID: 31709727 DOI: 10.1111/jcmm.14806] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
40 Liao W, Zhang J, Zhu Q, Qin L, Yao W, Lei B, Shi W, Yuan S, Tahir SA, Jin J, He S. Preoperative Neutrophil-to-Lymphocyte Ratio as a New Prognostic Marker in Hepatocellular Carcinoma after Curative Resection. Transl Oncol 2014;7:248-55. [PMID: 24704092 DOI: 10.1016/j.tranon.2014.02.011] [Cited by in Crossref: 45] [Cited by in F6Publishing: 55] [Article Influence: 5.6] [Reference Citation Analysis]
41 Song L, Zhang JG, Zheng L, Feng X, Hou J, Zhang HL, Liu SF. Establishment of rat liver cancer cell lines with different metastatic potential. Sci Rep 2020;10:8329. [PMID: 32433581 DOI: 10.1038/s41598-020-65338-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Zhang J, Pan Y, Ding Z, Yang G, Tan Y, Yang C, Jiang T, Liu L, Zhang B, Han T, Cao D, Yang T, Yang N, Wu M, Dong L, Wang H. RMP promotes venous metastases of hepatocellular carcinoma through promoting IL-6 transcription. Oncogene 2015;34:1575-83. [DOI: 10.1038/onc.2014.84] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]